Suzhou Industrial Park

Home page > News


Biomedicine, nanotech and AI: new engines for SIP’s development


Date:   |   Source:       Font Size:    A   A   A

The latest statistics show that output values in the biomedicine, nanotech and AI sectors in SIP reached around RMB 80 billion, 66 billion and 25 billion last year, maintaining an average annual growth of about 30%. It indicates that these emerging industries that SIP has been sparing no efforts to develop have become new engines for the economic growth and industrial upgrading and transformation in the area.

SIP’s BioBay is reportedly home to over 400 biomedicine enterprises which, together with about 10,000 high-caliber professionals and a host of research institutes, have formed an integrated ecosystem for development of new drugs and therapies. In one example, CStone Pharmaceuticals, which was listed at Hong Kong Exchanges and Clearing Market on Feb 26, has achieved a robust development of innovative immuno-oncology and molecularly targeted drugs.

On the other hand, SIP has gathered nearly 600 nanotech businesses and a number of research institutes with best-in-class nanotech development facilities. For example, there is NanoMicro, a company developing world-leading technologies for production of uniformly sized nano- and microspheres (microparticles), and Chinese Academy of Sciences’ Suzhou Institute of Nano-tech and Nano-bionics which owns the world’s largest multifunctional nanoscience and nanotech research platform Nano-X.

The AI sector currently sees nearly 600 enterprises and a multitude of laboratories and other research projects. Among the representatives are AISpeech, a domestically leading natural language interaction solution supplier, and Shanghai Jiao Tong University (Suzhou) AI Research Institute.

SIP offers full support to the industries which, in return, are helping boost a strong development of related upstream and downstream industries as well as facilitate cross-industry cooperation.

Lianhe Zaobao,
April 12, 2019